SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

US boost for Ranbaxy net

Oct 29, 2014 at 03:42 | Source: Calcutta Telegraph News

Mumbai, Oct. 28: Ranbaxy Laboratories today reported its first net profit in six quarters, gaining from the exclusive US launch of a cheaper copy of Novartis�s blood pressure pill Diovan. The drug firm, which is being bought by larger rival Sun Ph...

Cadila recalls drug in US

Oct 18, 2014 at 20:22 | Source: Calcutta Telegraph News

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was volu...

Ranbaxy buys Texas peace

Oct 17, 2014 at 12:32 | Source: Calcutta Telegraph News

Mumbai, Oct. 16: Ranbaxy Laboratories today said it would pay $39.75 million (Rs 244 crore) to the state of Texas in the US to settle the litigation with regard to its participation in a social health scheme meant for the poor. “The company ha...

Strides, Shasun pop merger pill

Sep 30, 2014 at 12:57 | Source: Calcutta Telegraph News

Mumbai, Sept: 29: Chennai-based Shasun Pharmaceuticals Ltd will be merged with generic drug maker Strides Arcolab to create a Rs 2,500-crore entity spanning across multiple segments. The merged entity will figure among the top 15 listed Indian pharm...

Corporate India s legal costs increase 17.5% in 2013-14

Sep 27, 2014 at 13:17 | Source: Economic Times

MUMBAI: An overhead cost is steadily expanding for Indian companies as they aggressively push in overseas markets and regulations become tougher at home and abroad. More than 1,800 listed companies that the ET Intelligence Group has analysed have col...

Drug firms get part price relief

Sep 24, 2014 at 04:47 | Source: Calcutta Telegraph News

New Delhi, Sept. 23: The government has withdrawn the national drug pricing authority’s power to set prices of non-essential medicines, but price caps on the over 100 non-essential drugs that drew the industry’s ire in July will remain. ...

Ranbaxy under US lens

Sep 18, 2014 at 04:37 | Source: Calcutta Telegraph News

Mumbai, Sept. 17: Ranbaxy Laboratories today said the US justice department had asked it to disclose the way it priced some drugs it sold in America. The Indian company, in fact, had made a provision of Rs 237.75 crore in the first quarter but had n...

Ranbaxy says U.S. authorities seek information on pricing data

Sep 18, 2014 at 00:45 | Source: FirstPost

MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid ...

Ranbaxy relief

Sep 14, 2014 at 12:02 | Source: Calcutta Telegraph News

Sept. 13 (Reuters): Pfizer Inc and Ranbaxy Laboratories on Friday won dismissal of a US anti-trust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. US District Judge Peter Sheridan ...

Nifty retreats from record high on profit taking

Aug 21, 2014 at 00:51 | Source: FirstPost

MUMBAI (Reuters) - The Nifty edged lower on Wednesday, unable to sustain a rally after hitting a third consecutive record high earlier in session as investors took profits in blue-chips such as Oil and Natural Gas Corp(ONGC.NS).The falls ended a six-...

Sun bid to address monopoly concern

Aug 14, 2014 at 04:07 | Source: Calcutta Telegraph News

Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India (CCI) to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector. The fair trade watch...

Ranbaxy suffers loss

Jul 31, 2014 at 01:52 | Source: Calcutta Telegraph News

Mumbai, July 29: Ranbaxy Laboratories has suffered a net loss of Rs 185.92 crore for the quarter ended June 30 as it was bogged down by a “settlement provision’’ of nearly Rs 237.75 crore. The company, which is dealing with an impo...

Ipca halts drug exports to US

Jul 25, 2014 at 08:12 | Source: Calcutta Telegraph News

Mumbai, July 24: Ipca Laboratories today said it was voluntarily suspending shipments of drug ingredients from one of its plants in the country, following concerns expressed by the US Food and Drug Administration (FDA). The mid-sized company said th...

Sun Pharma pops buyout pill again

Jul 17, 2014 at 03:47 | Source: Calcutta Telegraph News

Mumbai, July 16: After a blockbuster deal to acquire Ranbaxy Laboratories, Sun Pharma today announced that it was buying US-based Pharmalucence Inc for an undisclosed amount. Pharmalucence, which has sterile injectable capacity in the US, has been a...

India supplies pharma to 200 countries; but heavily dependent itself on imports from China: ASSOCHAM Study

Jul 04, 2014 at 20:17 | Source: Assocham

Alongside India building an unenviable reputation of being the pharmacy of the world supplying reliable and affordable medicines to over 200 countries, lesser known fact is that the country has become heavily import dependent on China when it comes ...

US booster dose for Ranbaxy

Jun 28, 2014 at 12:37 | Source: Calcutta Telegraph News

Mumbai, June 27: Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell Valsartan tablets in the American market. Valsartan is the generic version of Novartis’s Diovan, a highly successful drug with ...

Infosys launches solution to tap clinical trial market

Jun 05, 2014 at 05:47 | Source: Economic Times

NEW DELHI: The country's second largest software services firm Infosys today launched a cloud-based version of its clinical trial supply management solution (CTSM) that will offer pharmaceutical firms reduced cost and faster time to market the new d...

Sun Pharma Q4 net profit up 57%

May 29, 2014 at 20:22 | Source: Economic Times

Sun Pharmaceutical Industries Ltd , India's third-largest drugmaker by revenue, on Thursday reported a 57 percent jump in fourth-quarter net profit, slightly above expectations, helped by higher sales in the United States, its largest market. The com...

Sun Pharma Q4 PAT surges 56.8 per cent to Rs 1587 crore

May 29, 2014 at 20:22 | Source: Economic Times

MUMBAI: Sun Pharmaceutical Industries, which is in the process of acquiring rival drug maker Ranbaxy Laboratories, posted a better-than-expected 57% jump in fourth-quarter net profit, as sales continued to grow at a healthy pace in the key US market...

Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

May 21, 2014 at 14:46 | Source: FirstPost

New Delhi: The Supreme Court today asked the Andhra Pradesh High Court, which had passed an interim order staying the $4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days.Hearing appeals filed by Sun Pharmaceutical, Ranba...

video of the day

See 7% GDP by FY17; like pvt banks, autos: Kotak's Prasad

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.